Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023.

Saved in:
Bibliographic Details
Title: Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023.
Authors: Fontán-Vela M; National Centre of Epidemiology, Carlos III National Health Institute (ISCIII), Madrid, Spain.; Public Health and Epidemiology research group, School of Medicine and Health Sciences, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain., Kissling E; Epiconcept, Paris, France., Nicolay N; Vaccine Preventable Diseases and Immunisation, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden., Braeye T; Sciensano, Elsene, Belgium., Van Evercooren I; Sciensano, Elsene, Belgium., Holm Hansen C; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut (SSI), Copenhagen, Denmark., Emborg HD; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut (SSI), Copenhagen, Denmark., Fabiani M; Infectious Diseases Department, Istituto Superiore di Sanità, Rome, Italy., Mateo-Urdiales A; Infectious Diseases Department, Istituto Superiore di Sanità, Rome, Italy., AlKerwi A; Ministry of Health, Directorate of Health, Service epidemiology and statistics, Luxembourg., Schmitz S; Ministry of Health, Directorate of Health, Service epidemiology and statistics, Luxembourg., Castilla J; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain., Martínez-Baz I; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain., de Gier B; Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Hahné S; Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Meijerink H; Norwegian Institute of Public Health (NIPH), Oslo, Norway., Starrfelt J; Norwegian Institute of Public Health (NIPH), Oslo, Norway., Nunes B; Departamento de Epidemiologia, Instituto Nacional de Saúde Doutor Ricardo Jorge, Departamento de Epidemiologia, Lisboa, Portugal., Caetano C; Departamento de Epidemiologia, Instituto Nacional de Saúde Doutor Ricardo Jorge, Departamento de Epidemiologia, Lisboa, Portugal., Derrough T; Vaccine Preventable Diseases and Immunisation, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden., Nardone A; Epiconcept, Paris, France., Monge S; National Centre of Epidemiology, Carlos III National Health Institute (ISCIII), Madrid, Spain.; CIBER on Infectious Diseases (CIBERINFEC), Madrid, Spain.
Corporate Authors: VEBIS-Lot4 working group; The members of the VEBIS-Lot4 working group are listed under Collaborators., VEBIS-Lot 4 working group
Source: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2024 Jan; Vol. 29 (1).
Publication Type: Journal Article
Journal Info: Publisher: European Centre for Disease Prevention and Control (ECDC) Country of Publication: Sweden NLM ID: 100887452 Publication Model: Print Cited Medium: Internet ISSN: 1560-7917 (Electronic) Linking ISSN: 1025496X NLM ISO Abbreviation: Euro Surveill Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1560-7917
DOI:10.2807/1560-7917.ES.2024.29.1.2300670